MoonLake ImmunotherapeuticsNASDAQ:MLTX
- LAST PRICE57.2908
- TODAY'S CHANGE (%)0.6308 (1.1133%)
- Bid / Lots57.0900/ 4
- Ask / Lots57.4900/ 4
- Open / Previous Close57.1500 / 56.6600
- Day Range
- 52 Week Range
- Volume298,205
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MLTX |
|---|---|---|
| 09:32 ET | 1186 | 57.15 |
| 09:34 ET | 100 | 57.2 |
| 09:36 ET | 409 | 56.74 |
| 09:38 ET | 429 | 56.995 |
| 09:39 ET | 399 | 56.7 |
| 09:41 ET | 200 | 57.195 |
| 09:43 ET | 400 | 56.795 |
| 09:45 ET | 300 | 56.755 |
| 09:48 ET | 300 | 56.66 |
| 09:50 ET | 100 | 56.835 |
| 09:52 ET | 300 | 56.57 |
| 09:54 ET | 332 | 56.68 |
| 09:56 ET | 1800 | 56.585 |
| 09:57 ET | 705 | 56.21 |
| 09:59 ET | 100 | 56.7 |
| 10:01 ET | 2240 | 56.69 |
| 10:03 ET | 3500 | 57.01 |
| 10:06 ET | 600 | 57.175 |
| 10:08 ET | 1200 | 57.42 |
| 10:10 ET | 1900 | 57.61 |
| 10:12 ET | 4241 | 57.59 |
| 10:14 ET | 800 | 57.74 |
| 10:15 ET | 2700 | 57.66 |
| 10:17 ET | 2122 | 57.56 |
| 10:19 ET | 4936 | 57.59 |
| 10:21 ET | 1162 | 57.9 |
| 10:24 ET | 3200 | 57.695 |
| 10:26 ET | 1900 | 57.64 |
| 10:28 ET | 3058 | 57.525 |
| 10:30 ET | 573 | 57.675 |
| 10:32 ET | 4050 | 57.79 |
| 10:33 ET | 4016 | 57.57 |
| 10:35 ET | 3866 | 57.71 |
| 10:37 ET | 3472 | 57.76 |
| 10:39 ET | 3333 | 57.81 |
| 10:42 ET | 3658 | 57.78 |
| 10:44 ET | 2200 | 57.725 |
| 10:46 ET | 1559 | 57.83 |
| 10:48 ET | 4251 | 57.71 |
| 10:50 ET | 2040 | 57.68 |
| 10:51 ET | 1425 | 57.465 |
| 10:53 ET | 5098 | 57.57 |
| 10:55 ET | 3492 | 57.5 |
| 10:57 ET | 5150 | 57.68 |
| 11:00 ET | 1100 | 57.465 |
| 11:02 ET | 3889 | 57.77 |
| 11:04 ET | 2841 | 57.6 |
| 11:06 ET | 3500 | 57.51 |
| 11:08 ET | 2078 | 57.53 |
| 11:09 ET | 6304 | 57.56 |
| 11:11 ET | 3149 | 57.51 |
| 11:13 ET | 2300 | 57.58 |
| 11:15 ET | 2020 | 57.68 |
| 11:18 ET | 3633 | 57.58 |
| 11:20 ET | 2985 | 57.53 |
| 11:22 ET | 2100 | 57.57 |
| 11:24 ET | 2000 | 57.5 |
| 11:26 ET | 4330 | 57.5 |
| 11:27 ET | 3000 | 57.56 |
| 11:29 ET | 2617 | 57.47 |
| 11:31 ET | 2200 | 57.55 |
| 11:33 ET | 4156 | 57.4 |
| 11:36 ET | 3165 | 57.44 |
| 11:38 ET | 1098 | 57.485 |
| 11:40 ET | 3202 | 57.5 |
| 11:42 ET | 5811 | 57.53 |
| 11:44 ET | 3046 | 57.6 |
| 11:45 ET | 1629 | 57.56 |
| 11:47 ET | 3800 | 57.5 |
| 11:49 ET | 3100 | 57.48 |
| 11:51 ET | 8352 | 57.45 |
| 11:54 ET | 2215 | 57.45 |
| 11:56 ET | 5476 | 57.245 |
| 11:58 ET | 3542 | 57.22 |
| 12:00 ET | 9259 | 57.23 |
| 12:02 ET | 798 | 57.06 |
| 12:05 ET | 1956 | 57.16 |
| 12:09 ET | 414 | 57 |
| 12:12 ET | 100 | 57 |
| 12:14 ET | 3100 | 56.995 |
| 12:16 ET | 300 | 56.91 |
| 12:20 ET | 400 | 57.06 |
| 12:21 ET | 300 | 57.065 |
| 12:23 ET | 600 | 57.02 |
| 12:25 ET | 100 | 57.135 |
| 12:27 ET | 200 | 57.22 |
| 12:30 ET | 195 | 57.2225 |
| 12:32 ET | 793 | 57.22 |
| 12:34 ET | 1200 | 57.36 |
| 12:36 ET | 100 | 57.39 |
| 12:38 ET | 400 | 57.54 |
| 12:39 ET | 3000 | 57.42 |
| 12:41 ET | 100 | 57.41 |
| 12:43 ET | 200 | 57.43 |
| 12:45 ET | 430 | 57.351 |
| 12:48 ET | 738 | 57.38 |
| 12:50 ET | 100 | 57.39 |
| 12:52 ET | 515 | 57.31 |
| 12:54 ET | 500 | 57.205 |
| 12:57 ET | 120 | 57.2908 |
Sep 18, 2023
DJ MoonLake Immunotherap Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 12:07PM ET on Monday Sep 18, 2023 by Dow Jones
12:07PM ET on Monday Sep 18, 2023 by Dow JonesDJ MoonLake Immunotherap Price Target Maintained With a $86.00/Share by Wedbush, from 9:05AM ET on Monday Sep 18, 2023 by Dow Jones
9:05AM ET on Monday Sep 18, 2023 by Dow Jones
Sep 14, 2023
DJ MoonLake Immunotherap Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:18AM ET on Thursday Sep 14, 2023 by Dow Jones
9:18AM ET on Thursday Sep 14, 2023 by Dow Jones
Sep 12, 2023
DJ MoonLake Immunotherap Is Maintained at Equal-Weight by Barclays, from 12:26PM ET on Tuesday Sep 12, 2023 by Dow Jones
12:26PM ET on Tuesday Sep 12, 2023 by Dow JonesDJ MoonLake Immunotherap Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:14AM ET on Tuesday Sep 12, 2023 by Dow Jones
9:14AM ET on Tuesday Sep 12, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MoonLake Immunotherapeutics | 3.0B | -63.0x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Mirati Therapeutics Inc | 3.1B | -3.4x | --- |
Revolution Medicines Inc | 3.1B | -8.9x | --- |
Madrigal Pharmaceuticals Inc | 2.8B | -7.9x | --- |
Krystal Biotech Inc | 3.3B | -21.2x | --- |
Company Information
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Contact Information
- Headquarters
- Dorfstrasse 29ZUG, ZUG, Switzerland 6300
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Simon Sturge
- Chief Executive Officer, Director
- Jorge Santos Da Silva
- Chief Financial Officer
- Matthias Bodenstedt
- Chief Scientific Officer
- Kristian Reich
- Independent Director
- Kara Lassen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.91 |
Book Value | $1.25 |
P/E Ratio | -63.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
